Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

TAVR in CAD patients: A new approach | Roxana Mehran elected ACC president | Wearable tech company raises $575M

News You Need to Know Today
TAVR in CAD patients: A new approach | Roxana Mehran elected ACC president | Wearable tech company raises $575M
Wednesday, April 1, 2026
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

PCI before TAVR? In older CAD patients, deferral may be the best approach

Patients with coronary artery disease and severe aortic stenosis often undergo PCI before TAVR. According to new data presented at ACC.26, however, deferring PCI is associated with comparable outcomes as well as a reduced bleeding risk.

READ MORE >
Michiel Voskuil, MD, PhD, an interventional cardiologist and professor at University Medical Center Utrecht in the Netherlands, presented his team’s data on the ACC.26 stage.
Share on Twitter Share on Facebook Share on Linkedin

PCI before TAVR? In older CAD patients, deferral may be the best approach

Share on Twitter Share on Facebook Share on Linkedin
Michiel Voskuil, MD, PhD, an interventional cardiologist and professor at University Medical Center Utrecht in the Netherlands, presented his team’s data on the ACC.26 stage.
Patients with coronary artery disease and severe aortic stenosis often undergo PCI before TAVR. According to new data presented at ACC.26, however, deferring PCI is associated with comparable outcomes as well as a reduced bleeding risk.
READ MORE >

Interventional cardiologist Roxana Mehran elected ACC president

A prominent figure in the fields of interventional cardiology and women’s health is now leading the American College of Cardiology.

READ MORE >
Interventional cardiologist Roxana Mehran, MD, officially started her one-year term as the president of the American College of Cardiology (ACC) on the closing day of ACC.26, the group’s annual conference in New Orleans.
Share on Twitter Share on Facebook Share on Linkedin

Interventional cardiologist Roxana Mehran elected ACC president

Share on Twitter Share on Facebook Share on Linkedin
Interventional cardiologist Roxana Mehran, MD, officially started her one-year term as the president of the American College of Cardiology (ACC) on the closing day of ACC.26, the group’s annual conference in New Orleans.
A prominent figure in the fields of interventional cardiology and women’s health is now leading the American College of Cardiology.
READ MORE >

Whoop raises $575M—Abbott, LeBron James, Cristiano Ronaldo among the investors

Whoop, a Boston-based wearable technologies company, raised the new funding on a $10.1 billion evaluation.

READ MORE >
Whoop, a Boston-based wearable technologies company, has raised $575 million in new financing at a $10.1 billion valuation. Investors include Abbott, Mayo Clinic, LeBron James and Cristiano Ronaldo.
Share on Twitter Share on Facebook Share on Linkedin

Whoop raises $575M—Abbott, LeBron James, Cristiano Ronaldo among the investors

Share on Twitter Share on Facebook Share on Linkedin
Whoop, a Boston-based wearable technologies company, has raised $575 million in new financing at a $10.1 billion valuation. Investors include Abbott, Mayo Clinic, LeBron James and Cristiano Ronaldo.
Whoop, a Boston-based wearable technologies company, raised the new funding on a $10.1 billion evaluation.
READ MORE >

Featured Articles

FDA clears new AI model for pulmonary hypertension

The advanced algorithm, which previously received the FDA's breakthrough device designation, detects signs of pulmonary hypertension in standard 12-lead electrocardiograms.

READ MORE >
AI model algorithm tablet digital patient data
Share on Twitter Share on Facebook Share on Linkedin

FDA clears new AI model for pulmonary hypertension

Share on Twitter Share on Facebook Share on Linkedin
AI model algorithm tablet digital patient data
The advanced algorithm, which previously received the FDA's breakthrough device designation, detects signs of pulmonary hypertension in standard 12-lead electrocardiograms.
READ MORE >

New stroke prevention device for TAVR holds its own in head-to-head battle with Sentinel

A new embolic protection device from Emboline was noninferior to the FDA-approved Sentinel device in terms of safety and efficacy. In addition, it captured much more TAVR-generated debris and was linked to an improved technical success rate. 

READ MORE >
Adam Greenbaum, MD, presents late-breaking data at ACC.26.
Share on Twitter Share on Facebook Share on Linkedin

New stroke prevention device for TAVR holds its own in head-to-head battle with Sentinel

Share on Twitter Share on Facebook Share on Linkedin
Adam Greenbaum, MD, presents late-breaking data at ACC.26.
A new embolic protection device from Emboline was noninferior to the FDA-approved Sentinel device in terms of safety and efficacy. In addition, it captured much more TAVR-generated debris and was linked to an improved technical success rate. 
READ MORE >

‘Practice-changing’ interventional cardiology research grabs ACC.26 spotlight

The second day of the American College of Cardiology’s annual conference started with a series of highly anticipated interventional cardiology trials.

READ MORE >
Divaka Perera, MD, at ACC.26
Share on Twitter Share on Facebook Share on Linkedin

‘Practice-changing’ interventional cardiology research grabs ACC.26 spotlight

Share on Twitter Share on Facebook Share on Linkedin
Divaka Perera, MD, at ACC.26
The second day of the American College of Cardiology’s annual conference started with a series of highly anticipated interventional cardiology trials.
READ MORE >

Catheter-based treatment linked to major benefits for intermediate-risk PE

New 30-day data presented at ACC.26 helped answer questions cardiologists have had been asking for years. “Thank you for bringing PE into the future," one vascular specialist said from the stage.  

READ MORE >
 Stavros V. Konstantinides, MD, PhD, presenting data at ACC.26
Share on Twitter Share on Facebook Share on Linkedin

Catheter-based treatment linked to major benefits for intermediate-risk PE

Share on Twitter Share on Facebook Share on Linkedin
 Stavros V. Konstantinides, MD, PhD, presenting data at ACC.26
New 30-day data presented at ACC.26 helped answer questions cardiologists have had been asking for years. “Thank you for bringing PE into the future," one vascular specialist said from the stage.  
READ MORE >

In Case You Missed It

Cardiology now has more than 200 FDA-cleared AI algorithms

Cardiology is No. 2 behind radiology when it comes to FDA-cleared AI algorithms. Neurology, meanwhile, is a distant No. 3. 

READ MORE >
Ligence Heart is a recently FDA cleared AI that fully automates analyses, measurements and reporting for transthoracic echo.
Share on Twitter Share on Facebook Share on Linkedin

Cardiology now has more than 200 FDA-cleared AI algorithms

Share on Twitter Share on Facebook Share on Linkedin
Ligence Heart is a recently FDA cleared AI that fully automates analyses, measurements and reporting for transthoracic echo.
Cardiology is No. 2 behind radiology when it comes to FDA-cleared AI algorithms. Neurology, meanwhile, is a distant No. 3. 
READ MORE >

Moderate valve oversizing during TAVR boosts survival—too much may be less beneficial

Oversizing transcatheter heart valves can improve TAVR outcomes. There is still a reason to be cautious, however, especially when patients are receiving a balloon-expandable valve.

READ MORE >
Newsweek ranked the 50 best heart hospitals in the world
Share on Twitter Share on Facebook Share on Linkedin

Moderate valve oversizing during TAVR boosts survival—too much may be less beneficial

Share on Twitter Share on Facebook Share on Linkedin
Newsweek ranked the 50 best heart hospitals in the world
Oversizing transcatheter heart valves can improve TAVR outcomes. There is still a reason to be cautious, however, especially when patients are receiving a balloon-expandable valve.
READ MORE >

Next-generation guide extension catheter delivers value during complex PCI

The CrossFAST system was successfully used to deploy multiple stents after other devices fell short. 

READ MORE >
Angiography demonstrates a high-grade, modestly angulated stenosis (arrow) in the proximal segment of a large diagonal branch (A). Predilation performed with difficulty, and the GEC could not be advanced beyond stenosis even with “inch worming” techniques. (B). Advancement of the CrossFAST (C) beyond the proximal stent edge stenosis (a.), the position of the distal end of the outer catheter (b.), and the microcatheter tip (c.) are indicated. Photo courtesy of JSCAI
Share on Twitter Share on Facebook Share on Linkedin

Next-generation guide extension catheter delivers value during complex PCI

Share on Twitter Share on Facebook Share on Linkedin
Angiography demonstrates a high-grade, modestly angulated stenosis (arrow) in the proximal segment of a large diagonal branch (A). Predilation performed with difficulty, and the GEC could not be advanced beyond stenosis even with “inch worming” techniques. (B). Advancement of the CrossFAST (C) beyond the proximal stent edge stenosis (a.), the position of the distal end of the outer catheter (b.), and the microcatheter tip (c.) are indicated. Photo courtesy of JSCAI
The CrossFAST system was successfully used to deploy multiple stents after other devices fell short. 
READ MORE >

In Other News

Hospitals used illegal tactics to prevent patients from seeking low-cost radiology services: DOJ

Authorities claim NewYork-Presbyterian wielded plan restrictions to stop one insurer from steering beneficiaries to other imaging options. 

READ MORE >
Department of Justice DOJ
Share on Twitter Share on Facebook Share on Linkedin

Hospitals used illegal tactics to prevent patients from seeking low-cost radiology services: DOJ

Share on Twitter Share on Facebook Share on Linkedin
Department of Justice DOJ
Authorities claim NewYork-Presbyterian wielded plan restrictions to stop one insurer from steering beneficiaries to other imaging options. 
READ MORE >

Physicians who feel they ‘fit in’ experience less burnout—and entertain fewer thoughts of quitting or cutting back

Three-fifths of 14,000 physicians surveyed, 60%, enjoy a strong sense of belonging within their organization. Better yet, four-fifths, 80%, feel their teammates have their back.

READ MORE >
Happy doctor physician
Share on Twitter Share on Facebook Share on Linkedin

Physicians who feel they ‘fit in’ experience less burnout—and entertain fewer thoughts of quitting or cutting back

Share on Twitter Share on Facebook Share on Linkedin
Happy doctor physician
Three-fifths of 14,000 physicians surveyed, 60%, enjoy a strong sense of belonging within their organization. Better yet, four-fifths, 80%, feel their teammates have their back.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

TAVR Highlights: Self-expanding valves continue to impress | A new technique | Why implant depth matters | SAPT vs. DAPT
Recall announced after 3 injuries | Medical societies respond to government report | New-look pacemaker requires no implant
Is coffee bad for the heart? | FDA approves new hypertension drug | Stolen devices sold to patients | BP drug recalled
OIG questions vascular procedures | Things to consider before signing your next contract | Is coffee bad for the heart?
Looking Back: Cardiovascular care hit by major recalls | New payment model on the way | SMART update | Trends in cardiac CT
Another Impella warning | Devices stolen, sold to patients | FDA impressed by new AI software | SAPT after TAVR
Week in Review: FDA confirms recall for vascular device | BATMAN to the rescue | Prasugrel after PCI | GLP-1 drugs & AFib

Pagination

    • Current page 1
    • Page 2
    • Page 3
    • Page 4
    • Page 5
    • Page 6
    • Page 7
    • Page 8
    • Page 9 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme
Trimed Popup